Michael Nofi
Net worth: - $ as of 2026-08-30
Net worth: - $ as of 2026-08-30
Michael P.
Nofi is currently Chief Financial Officer at Parlux Fragrances LLC and will be Chief Financial Officer at Edgewise Therapeutics, Inc. starting in 2025.
Formerly, Mr. Nofi was Chief Financial Officer at Perfumania Holdings, Inc. from 2017 to 2018 and Chief Accounting Officer at Springworks Therapeutics, Inc. from 2019 to 2025.
Mr. Nofi completed undergraduate studies at Villanova University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-11 | 0 ( -.--% ) | - $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Director of Finance/CFO | 2025-11-09 |
Parlux Fragrances LLC
Parlux Fragrances LLC Household/Personal CareConsumer Non-Durables Manufactures a broad line of toiletries, perfumes and colognes | Director of Finance/CFO | - |
| Companies | Position | End |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2025-06-30 |
| PERFUMANIA HOLDINGS, INC. | Director of Finance/CFO | 2018-09-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Parlux Fragrances LLC
Parlux Fragrances LLC Household/Personal CareConsumer Non-Durables Manufactures a broad line of toiletries, perfumes and colognes | Consumer Non-Durables |
Perfumania Holdings, Inc.
Perfumania Holdings, Inc. Specialty StoresRetail Trade Retails and distributes perfumes & fragrances | Retail Trade |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Springworks Therapeutics, Inc.
Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions